Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins - A molecular link of two tumor suppressor pathways

被引:25
作者
Birchenall-Roberts, MC
Fu, T
Bang, OS
Dambach, M
Resau, JH
Sadowski, CL
Bertolette, DC
Lee, HJ
Kim, SJ
Ruscetti, FW
机构
[1] NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA
[2] Van Andel Inst, Grand Rapids, MI 49506 USA
[3] NCI Frederick, Expt Immunol Lab, Frederick, MD 21702 USA
[4] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M402790200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Tuberin (TSC2) is a tumor suppressor gene. At the cellular level, tuberin is required as a critical regulator of cell growth, neuronal differentiation (Soucek, T., Holzl, G., Bernaschek, G., and Hengstschlager, M. (1998) Oncogene 16, 2197-2204), and tumor suppression (Crino, P. B., and Henske, E. P. (1999) Neurology 53, 1384-1390). Here we report a critical role for tuberin in late stage myeloid cell differentiation. Tuberin strongly augments transforming growth factor (TGF)-beta1 signal transduction pathways, including SMAD activation. We also demonstrate that the amino-terminal region of tuberin interacts specifically with the MH2 domain of SMAD2 and SMAD3 proteins to regulate TGF-beta1-responsive genes such as p21(CIP). Inhibition of tuberin expression by Tsc2 antisense greatly reduces the ability of TGF-beta to transcriptionally regulate p21(CIP), p27(KIP), and cyclin A leading to an abrogation of the antiproliferative effects of TGF-beta1. Also, inhibition of tuberin expression during stimulation of monocytic differentiation with vitamin D-3 and TGF-beta1 significantly impaired myeloid cell growth inhibition and differentiation. Together, the data demonstrate the presence of a novel activation process following TGF-beta1 stimulation that requires tuberin-dependent activity.
引用
收藏
页码:25605 / 25613
页数:9
相关论文
共 41 条
[1]
Signal transduction by the TGF-β superfamily [J].
Attisano, L ;
Wrana, JL .
SCIENCE, 2002, 296 (5573) :1646-1647
[2]
Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients [J].
Au, KS ;
Rodriguez, JA ;
Finch, JL ;
Volcik, KA ;
Roach, ES ;
Delgado, MR ;
Rodriguez, E ;
Northrup, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :286-294
[3]
BIRCHENALLROBERTS MC, 1995, MOL CELL BIOL, V15, P6088
[4]
Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-β and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells [J].
Cao, ZH ;
Flanders, KC ;
Bertolette, D ;
Lyakh, LA ;
Wurthner, JU ;
Parks, WT ;
Letterio, JJ ;
Ruscetti, FW ;
Roberts, AB .
BLOOD, 2003, 101 (02) :498-507
[5]
Chatterjee D, 1997, CELL GROWTH DIFFER, V8, P1083
[6]
New developments in the neurobiology of the tuberous sclerosis complex [J].
Crino, PB ;
Henske, EP .
NEUROLOGY, 1999, 53 (07) :1384-1390
[7]
TRANSFORMING GROWTH-FACTOR-BETA INDUCES THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 THROUGH A P53-INDEPENDENT MECHANISM [J].
DATTO, MB ;
LI, Y ;
PANUS, JF ;
HOWE, DJ ;
XIONG, Y ;
WANG, XF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5545-5549
[8]
Intracellular signalling: The Mad way to do it [J].
Derynck, R ;
Zhang, Y .
CURRENT BIOLOGY, 1996, 6 (10) :1226-1229
[9]
Cyclin A down-regulation in TGFβ1-arrested follicular lymphoma cells [J].
Djaborkhel, R ;
Tvrdík, D ;
Eckschlager, T ;
Raska, I ;
Müller, J .
EXPERIMENTAL CELL RESEARCH, 2000, 261 (01) :250-259
[10]
TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA)-INDUCED DOWN-REGULATION OF CYCLIN-A EXPRESSION REQUIRES A FUNCTIONAL TGF-BETA RECEPTOR COMPLEX - CHARACTERIZATION OF CHIMERIC AND TRUNCATED TYPE-I AND TYPE-II RECEPTORS [J].
FENG, XH ;
FILVAROFF, EH ;
DERYNCK, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24237-24245